Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Vertex Pharmaceuticals Incorporated

Market Cap 11TCr 9.75TCr 8.99TCr 8.41TCr 16TCr 10,73400Cr 16TCr 1,06100Cr 41TCr 5,22400Cr 42TCr 41TCr 18,08900Cr P/E Ratio 2026 *
25.4x
P/E Ratio 2027 * 22.6x
Enterprise Value 10TCr 8.65TCr 7.97TCr 7.46TCr 14TCr 9,51800Cr 14TCr 94TCr 37TCr 4,63300Cr 38TCr 37TCr 16,04100Cr EV / Sales 2026 *
7.68x
EV / Sales 2027 * 6.71x
Free-Float
99.8%
Yield 2026 *
-
Yield 2027 * -
1 day-0.03%
1 week-0.43%
Current month-0.58%
1 month-1.80%
3 months-5.20%
6 months-1.57%
Current year-1.86%
1 week 433.8
Extreme 433.8
449.5
1 month 420.01
Extreme 420.01
453.45
Current year 412.27
Extreme 412.27
507.92
1 year 362.5
Extreme 362.5
507.92
3 years 335.82
Extreme 335.82
519.88
5 years 176.36
Extreme 176.36
519.88
10 years 71.46
Extreme 71.46
519.88
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2020
Director of Finance/CFO 58 10/04/2019
Chief Tech/Sci/R&D Officer - 01/07/2021
Director TitleAgeSince
Director/Board Member 66 01/01/1998
Chairman 70 01/05/2012
Director/Board Member 57 18/06/2015
Date Insider Type Main position Quantity % Market Cap.
05/06Sell

Chief Technology Officer

-1,745 0.0007%
01/06Sell

General Counsel

-828 0.0003%
29/05Sell

Chief Technology Officer

-1,974 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%-0.43%-2.31%+30.06% 11TCr
-2.41%+0.14%+38.28%+154.20% 1,01000Cr
+1.07%+3.48%+53.32%+49.85% 58TCr
+1.32%+0.22%+19.18%+64.65% 40TCr
+0.77%0.00%+21.28%+16.70% 33TCr
-1.42%-1.44%+45.70%+8.24% 29TCr
-0.85%-2.86%+22.54%+14.67% 28TCr
+0.44%+3.48%+25.65%+35.66% 28TCr
+1.66%+1.20%-44.35%-47.35% 20TCr
+0.32%+1.61%+20.32%+60.01% 19TCr
Average +0.09%+0.85%+19.96%+38.67% 36.8TCr
Weighted average by Cap. -0.32%+0.95%+28.85%+64.76%

Financials

2026 *2027 *
Net sales 1.3TCr 1.13TCr 1.04TCr 971.32Cr 1.82TCr 1,23900Cr 1.85TCr 12TCr 4.78TCr 60TCr 4.89TCr 4.79TCr 2,08900Cr 1.43TCr 1.23TCr 1.14TCr 1.06TCr 1.99TCr 1,35600Cr 2.02TCr 13TCr 5.23TCr 66TCr 5.35TCr 5.24TCr 2,28500Cr
Net income 445.12Cr 384.45Cr 354.27Cr 331.62Cr 621.47Cr 42TCr 631.1Cr 4.18TCr 1.63TCr 21TCr 1.67TCr 1.63TCr 71TCr 505.3Cr 436.43Cr 402.17Cr 376.45Cr 705.49Cr 48TCr 716.41Cr 4.75TCr 1.85TCr 23TCr 1.9TCr 1.86TCr 81TCr
Net Debt -1.28TCr -1.1TCr -1.02TCr -952.45Cr -1.78TCr -1,21500Cr -1.81TCr -12TCr -4.68TCr -59TCr -4.8TCr -4.7TCr -2,04800Cr -1.71TCr -1.48TCr -1.36TCr -1.28TCr -2.39TCr -1,62900Cr -2.43TCr -16TCr -6.28TCr -79TCr -6.43TCr -6.29TCr -2,74500Cr
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
Date Price Change Volume
12/26/12 444.92 $ -0.03% 9,24,189
11/26/11 445.04 $ +2.14% 12,33,868
10/26/10 435.71 $ -2.26% 11,03,240
09/26/09 445.77 $ +0.63% 8,71,497
08/26/08 442.96 $ -0.87% 11,49,408
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
444.92USD
Average target price
548.69USD
Spread / Average Target
+23.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VRTX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!